PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hypersensitivity D006967 22 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Hypotension D007022 41 associated lipids
Hypothermia D007035 19 associated lipids
Inflammation D007249 119 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Leiomyoma D007889 8 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Knapp HR Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. 1990 N. Engl. J. Med. pmid:1701029
Saitoh O et al. Effect of amogastrin on the release of various prostaglandins into gastric lumen in man. 1989 Mar-Apr Jpn. J. Med. pmid:2733241
Tejedor M et al. Potentiation of radiation toxicity in C-6 glioma cells by prostaglandin D2. 1989 Jul-Aug Anticancer Res. pmid:2817802
Kuiper J et al. Induction of ornithine decarboxylase in rat liver by phorbol ester is mediated by prostanoids from Kupffer cells. 1989 J. Biol. Chem. pmid:2708347
Kerr JS et al. Effects of recombinant interleukin-1 beta on phospholipase A2 activity, phospholipase A2 mRNA levels, and eicosanoid formation in rabbit chondrocytes. 1989 Biochem. Biophys. Res. Commun. pmid:2558648
Kawabe Y et al. Genesis and recovery of ethanol-induced gastric lesions in rats: possible involvement of prostaglandin D2. 1989 Am. J. Gastroenterol. pmid:2916522
Sakai T et al. Protection by cycloheximide against cytotoxicity induced by vincristine, colchicine, or delta 12-prostaglandin J2 on human osteosarcoma cells. 1989 Cancer Res. pmid:2917351
Phillips GD and Holgate ST Interaction of inhaled LTC4 with histamine and PGD2 on airway caliber in asthma. 1989 J. Appl. Physiol. pmid:2917934
Ban M et al. A flavonoid inhibitor of 5-lipoxygenase inhibits leukotriene production following ischemia in gerbil brain. 1989 Stroke pmid:2919414
Naclerio RM et al. The effect of cetirizine on early allergic response. 1989 Laryngoscope pmid:2566879
Wolfe LS et al. Synthesis and functions of cyclooxygenase and lipoxygenase products in brain: new findings and an appraisal. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2568735
Wolfe LS and Pellerin L Arachidonic acid metabolites in the rat and human brain. New findings on the metabolism of prostaglandin D2 and lipoxygenase products. 1989 Ann. N. Y. Acad. Sci. pmid:2570544
Bhattacharya SK et al. Effect of centrally administered prostaglandin D2 and some prostaglandin synthesis inhibitors on carrageenan-induced paw oedema in rats. 1989 J. Pharm. Pharmacol. pmid:2571705
Woodward DF et al. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure. 1989 Ophthalmic Res. pmid:2626239
Nishino S et al. Salivary prostaglandin concentrations: possible state indicators for major depression. 1989 Am J Psychiatry pmid:2627202
Charlesworth EN et al. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. 1989 J. Clin. Invest. pmid:2468688
Charlesworth EN et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. 1989 J. Allergy Clin. Immunol. pmid:2469708
Church MK et al. Mast cells, neuropeptides and inflammation. 1989 Agents Actions pmid:2473641
Robinson C et al. The metabolism of prostaglandin D2. Evidence for the sequential conversion by NADPH and NAD+ dependent pathways. 1989 Biochem. Pharmacol. pmid:2818626
van Overveld FJ Mediator release from human lung mast cell subtypes in chronic bronchitis and emphysema. 1989 Agents Actions pmid:2473645
Benyon RC et al. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. 1989 Br. J. Pharmacol. pmid:2474353
Emery DL et al. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. 1989 J. Appl. Physiol. pmid:2793725
Dubertret L et al. Biological and cellular responses to grass pollen in sensitive patients. 1989 Dermatologica pmid:2476344
Wachs M et al. Observations on the pathogenesis of nasal priming. 1989 J. Allergy Clin. Immunol. pmid:2477429
Yoshimura S et al. Prostaglandin D2 receptor of mastocytoma P-815 cells--possible regulation by phosphorylation and dephosphorylation. 1989 Biochim. Biophys. Acta pmid:2497784
Ikai K et al. Prostaglandin D2, a mediator in both immediate and delayed-type immune reactions in the skin. 1989 Dermatologica pmid:2506083
Hatanaka M et al. Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells. 1989 J. Neurochem. pmid:2507741
Urade Y et al. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. 1989 J. Immunol. pmid:2509561
Ito S et al. Prostaglandin D2: a biochemical perspective. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2510183
Lapointe DS and Olson MS Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. 1989 J. Biol. Chem. pmid:2501299
Virgolini I et al. Effects of taprostene, a chemically stable prostacyclin analogue, in patients with ischaemic peripheral vascular disease: a placebo controlled double-blind trial. 1989 Prostaglandins Leukot. Essent. Fatty Acids pmid:2514430
Robinson C et al. The IgE- and calcium-dependent release of eicosanoids and histamine from human purified cutaneous mast cells. 1989 J. Invest. Dermatol. pmid:2504819
Giles H et al. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. 1989 Br. J. Pharmacol. pmid:2924081
Beasley RC et al. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. 1989 J. Appl. Physiol. pmid:2525122
Hayaishi O Prostaglandin D2 and sleep. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526481
Watanabe Y et al. Positron emission tomography studies using [11C]ester of prostaglandin D2. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526503
Fukushima M et al. Prostaglandin A and J: antitumor and antiviral prostaglandins. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526507
Thierauch KH et al. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor. 1989 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2526554
Watanabe K [Structure and function of prostaglandin F synthetase]. 1989 Seikagaku pmid:2693551
Preclik G et al. Alimentary tract and pancreas. Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. 1989 Gut pmid:2703138
Napier FE and Temple DM The influence of xanthines on the contractile responses of PGF2 alpha and PGD2 in human parenchymal strips. 1989 Prostaglandins pmid:2772222
Dieter P et al. 4-Bromophenacyl bromide inhibits prostaglandin D2 synthesis from arachidonic acid rather than phospholipase A2 activity in liver macrophages. 1989 Biol. Chem. Hoppe-Seyler pmid:2775481
Coe JY et al. A fetal-instrumented model to study age-specific responses to leukotriene D4 and prostaglandin D2 in unsedated newborn lambs. 1989 Can. J. Physiol. Pharmacol. pmid:2776077
Ehara H [An experimental study on antitumor effect of prostaglandin D2]. 1989 Nihon Geka Gakkai Zasshi pmid:2796985
Thierauch KH et al. ZK 110 841--a selective and potent prostaglandin D2 analogue. 1989 Prog. Clin. Biol. Res. pmid:2798462
Ashida Y et al. A novel anti-asthmatic quinone derivative, AA-2414 with a potent antagonistic activity against a variety of spasmogenic prostanoids. 1989 Prostaglandins pmid:2748922
Raisz LG and Woodiel FN Effect of alterations in the cyclopentane ring on bone resorptive activity of prostaglandin. 1989 Prostaglandins pmid:2727307
Wolfe LS et al. Metabolism of prostaglandin D2 by human cerebral cortex into 9 alpha, 11 beta-prostaglandin F2 by an active NADPH-dependent 11-ketoreductase. 1989 J. Neurochem. pmid:2723663
Hayaishi O Prostaglandin D2 and sleep. 1989 Ann. N. Y. Acad. Sci. pmid:2774407
Rodriguez y Baena R et al. Effects of nicardipine on the ex vivo release of eicosanoids after experimental subarachnoid hemorrhage. 1989 J. Neurosurg. pmid:2585083